EAST.H — EastWest Bioscience Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.21% | ||
| Return on Equity | 7.44% | ||
| Operating Margin | 64.41% | ||
Financial Summary
| Year End 31st Jul | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | 1.31 | 1.06 | n/a | n/a | -19.03% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eastwest Bioscience Inc. is a Canada-based vertically integrated wellness company. The Company has a multitude of business units and assets that allow for seed-to-sale supply chain management. The Company sources its raw materials, processes, manufactures, tests, brands, markets and distributes its products to its customers in Canada, the United States, and other countries. The Company owns and operates retail and manufacturing subsidiaries. Its retail subsidiary is a Canada-based natural health retail franchise, the Sangster's Health Centre's, which is involved in the health and wellness industry. Orchard Vale Naturals is the Company's manufacturing arm that is certified with a Health Canada Site License and has GMP Certified NHP Manufacturing capabilities. Orchard Vale Naturals is specialized in custom blends and production runs of all sizes, small to large. Orchard Vale Naturals operates out of the approximately 34,000 square Health Canada licensed facility in Penticton, British Col
Directors
- Last Annual
- July 31st, 2021
- Last Interim
- April 30th, 2022
- Incorporated
- October 24th, 2014
- Public Since
- March 6th, 2017
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 100,664,323
- Address
- 260 Okanagan East Ave, PENTICTON, V2A 3J7
- Web
- https://www.eastwestbioscience.com/
- Phone
- +1 6048076334
- Auditors
- DALE MATHESON CARR-HILTON LABONTE LLP
Upcoming Events for EAST.H
Similar to EAST.H
Automotive Finco
TSX Venture Exchange
Universal PropTech
TSX Venture Exchange
FAQ
As of Today at 19:07 UTC, shares in EastWest Bioscience are trading at . This share price information is delayed by 15 minutes.
Shares in EastWest Bioscience last closed at and the price had moved by +25% over the past 365 days. In terms of relative price strength the EastWest Bioscience share price has outperformed the Toronto Stock Exchange 300 Composite Index by +17.87% over the past year.
There is no consensus recommendation for this security.
EastWest Bioscience does not currently pay a dividend.
EastWest Bioscience does not currently pay a dividend.
EastWest Bioscience does not currently pay a dividend.
To buy shares in EastWest Bioscience you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of , shares in EastWest Bioscience had a market capitalisation of .
Here are the trading details for EastWest Bioscience:
- Country of listing: Canada
- Exchange: NEX
- Ticker Symbol: EAST.H
Based on an overall assessment of its quality, value and momentum EastWest Bioscience is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EastWest Bioscience. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +7.7%.
As of the last closing price of , shares in EastWest Bioscience were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The EastWest Bioscience PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at .
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on EastWest Bioscience's directors